인문학
사회과학
자연과학
공학
의약학
농수해양학
예술체육학
복합학
개인구독
소속 기관이 없으신 경우, 개인 정기구독을 하시면 저렴하게
논문을 무제한 열람 이용할 수 있어요.
지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
초록·키워드
Abstract Copper oxide nanoparticles (CuO NPs) show promise in biomedicine due to their stability and beneficial attributes, including antimicrobial, antifungal, and anticancer properties. However, their toxicity raises concerns that require improvements in biocompatibility. Doping with transition metals, like yttrium (Y), effectively addresses these issues while enhancing antioxidant activity. The present study aims to synthesize Y-doped CuO NPs and characterize them using scanning electron microscopy (SEM), energy-dispersive X-ray spectroscopy (EDX), transmission electron microscopy (TEM), Fourier transform infrared (FTIR) spectroscopy, and X-ray diffraction (XRD). The cytotoxic effect of Y–CuO NPs against human normal fibroblast (BJ-1) was evaluated. Furthermore, the study examines the bioactive properties of Y–CuO NPs, emphasizing their capabilities in antioxidant, anti-Alzheimer’s, anti-arthritic, and anti-diabetic potentials. A monoclinic crystalline structure of Y–CuO NPs was successfully synthesized with a mean size of 10.563 nm ± 2.204. Y–CuO NPs have low cytotoxic potential against BJ-1 cell lines, with an IC 50 of 335.93 ± 6.36 μg mL −1 . Y–CuO NPs (50, 100, 200 μg mL −1 ) show antioxidant activity, reducing total antioxidant capacity (TAC) and iron reducing power (IRP) dose-dependently. It shows the highest effect at 200 μg mL −1 , with TAC at 103.27 ± 0.87 mg gallic acid g −1 and IRP at 89.18 ± 1.08 μg mL −1 . Y–CuO NPs scavenge 50 % of DPPH radicals with an IC 50 value of 117.81 ± 0.40 μg mL −1 and 94.61 ± 0.13 μg mL −1 for ABTS. The nanoparticles’ scavenging activity shows an IC 50 of 159.35 ± 0.10 μg mL −1 for nitric oxide, 189.324 ± 0.20 μg mL −1 for OH, and 151.02 ± 0.03 μg mL −1 for H 2 O 2 , respectively. Y–CuO NPs show anti-Alzheimer’s, anti-arthritic, and anti-diabetic activities by inhibiting acetylcholinesterase (AChE) (IC 50 = 172.19 ± 0.14), proteinase (IC 50 = 155.96 ± 0.11), α-amylase (IC 50 = 103.39 ± 0.07), and (IC 50 = 144.41 ± 0.10) α-glucosidase enzymes, respectively. Y 3+ doping promotes the formation of oxygen vacancies that enhance redox and enzymatic activity in Y–CuO NPs. This study explores the biological potential of synthetically formed Y–CuO NPs for future biomedical uses. The findings are preliminary enzyme-inhibition screens awaiting in vivo confirmation.
인공지능 문자 인식 모델을 통해 추출된 텍스트로, 일부 오타나 오류가 포함될 수 있으나 지속적으로 개선 중입니다.
오류를 발견하셨다면 해당 부분을 드래그한 후 ' 를 통해 신고해주세요.
오류를 발견하셨다면 해당 부분을 드래그한 후 ' 를 통해 신고해주세요.